Submissions for consideration may be sent via Editorial Manager. E-mailed submissions are no longer accepted.

**First-author Submission Policy.** First authors of all submissions must have one of the following doctoral degrees: MD, DO, PhD, PharmD, or the international equivalent of a doctoral degree. In some cases, a board certified dermatologist may be required as a co-author. Submissions by first authors who do not have a doctoral degree (including medical students and PhD candidates, regardless of year of study) will not be considered for publication and will be returned to the submitting author. **For alternative publication options, please see NP+PA Perspectives in Dermatology (for NPs and PAs) or Emerging Authors in Dermatology sections below).**

Emerging Authors in Dermatology. A very select number of submissions with nondoctoral-degree first authors will be considered for the bi-annual JCAD article series titled “Emerging Authors in Dermatology,” which is published in the June and December issues of the journal. Submissions under consideration will undergo peer review, and will be accepted or not accepted for publication based on that peer review. The corresponding author will be notified if their submission is being considered for possible publication in the Emerging Authors section. All other submissions will be returned to the authors and will not be considered for publication. Please note that at least one coauthor of all Emerging Author submissions must hold a doctoral degree; in some cases, a Board Certified Dermatologist coauthor will be required. Intent to submit to the Emerging Authors series should be indicated in the cover letter of these submissions. 

NP+PA Perspectives in Dermatology submissions. To submit a manuscript to this JCAD supplement series, authors should follow JCAD’s standard submission process as outlined in these Author Guidelines, with the following exceptions: 1) one or more of the coauthors should hold either an NP or PA degree; 2) first authors must hold an NP, PA, MD, DO, and/or PhD degree (or the international equivalent thereof); and 3) when submitting the article via Editorial Manager, please select “NP+PA Perspectives in Dermatology” when prompted to choose a “section.” Accepted articles that are published in this supplement series will be indexed under the JCAD title in Pubmed Central, Scopus, EMBASE, and CINAHL Plus.

Conflict of Interest Disclosures. All authors should disclose any potential financial conflicts of interest relevant to the submitted manuscript.

Author and Copyright Forms. Upon submission, authors will be asked to complete and return an Author Form, which requires corresponding author information, authorship statement, and financial disclosure. Authors will also be asked to sign and return a copyright form. If the manuscript is accepted and published in The Journal of Clinical and Aesthetic Dermatology, authors must transfer copyright to Matrix Medical Communications. Download author form here. Download copyright form here.

Registration of Clinical Trials. As recommended by the ICMJE, The Journal of Clinical and Aesthetic Dermatology requires, as a condition of consideration for publication, registration of all clinical trials in a public trials registry that requires the minimum registration data set as determined by the ICMJE [visit http://www.icmje.org/ index.html#clin_trials for guidelines]. Please include the trial registry name, registration number, and the url for the registry in the abstract.

Protection of Research Participants. When reporting research involving human data, authors should indicate whether the procedures followed have been assessed by the responsible review committee (institutional and national), or if no formal ethics committee is available, were in accordance with the Helsinki Declaration as revised in 2013. If doubt exists whether the research was conducted in accordance with the Helsinki Declaration, the authors must explain the rationale for their approach and demonstrate that the institutional review body explicitly approved the doubtful aspects of the study. Approval by a responsible review committee does not preclude editors from forming their own judgment whether the conduct of the research was appropriate.  See www.icmje.org for more information.

Patient Consent. Identifying information, including names, initials, or hospital numbers, should not be published in written descriptions, photographs, or pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Informed consent for this purpose requires that an identifiable patient be shown the manuscript to be published. Authors should disclose to these patients whether any potential identifiable material might be available via the Internet as well as in print after publication. Patient consent should be written and archived with the authors. The authors must provide the journal with a written statement that attests that they have received and archived written patient consent. Nonessential identifying details should be omitted. Informed consent should be obtained if there is any doubt that anonymity can be maintained. For example, masking the eye region in photographs of patients is inadequate protection of anonymity, and thus will require patient consent. If identifying characteristics are de-identified, authors should provide assurance, and editors should so note, that such changes do not distort scientific meaning. See www.icmje.org for more information.

Animal Experiments. Manuscripts will be considered for publication only if the work follows international, national, and/or institutional guidelines for humane animal treatment and complies with relevant legislation; has been approved by the ethics review committee at the institution or practice at which the studies were conducted where such a committee exists; and for studies using client-owned animals, demonstrates a high standard (best practice) of veterinary care and involves informed client consent. Prior to acceptance of a manuscript, to verify compliance with the above policies, the authors must include a signed statement that legal and ethical requirements were met with regard to the humane treatment of animals described in the study. Author must also describe in Materials and Methods section(s) of the manuscript the ethical review committee approval process and the international, national, and/or institutional guidelines that were followed. See www.icmje.org for more information.

Inclusion of previously published materials. Any material submitted to The Journal of Clinical and Aesthetic Dermatology that is reproduced from previously published copyrighted material must be accompanied by a letter of permission from the copyright holder. All such material should include a full credit line (e.g., in the figure or table legend) acknowledging the original source. The author is responsible for obtaining the permission and is responsible for any associated fees.